What to Expect

Incorrect. High-quality CPR is continued while addressing any potential reversible causes in pediatric PEA.

Incorrect. Magnesium sulfate stabilizes cardiac cells and is the treatment of choice for torsades de pointes.

Incorrect. Epinephrine is administered at 0.01 mg/kg IV/IO every 3-5 minutes during neonatal resuscitation.

Incorrect. Switching roles every 2 minutes prevents rescuer fatigue and ensures high-quality chest compressions.

Incorrect. Ventilations are delivered every 6 seconds (10 breaths per minute) to ensure oxygenation without interrupting compressions.

Incorrect. Atropine is used to treat bradycardia caused by increased vagal tone or primary conduction abnormalities.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore organized cardiac activity.

Incorrect. The target oxygen saturation for neonates during the first 10 minutes is 80-85%, gradually increasing to 90-95% later.

Incorrect. Synchronized cardioversion is used to treat unstable VT with a pulse to restore a normal rhythm and improve hemodynamics.

Incorrect. Vasopressors help improve perfusion and cardiac output when fluid resuscitation alone is insufficient.

Incorrect. Epinephrine is the drug of choice for treating bradycardia when oxygenation and ventilation do not resolve the issue.

Incorrect. Intramuscular epinephrine is the first-line treatment for pediatric anaphylaxis, administered into the mid-thigh.

Incorrect. Epinephrine at 0.01 mg/kg IV/IO is administered every 3-5 minutes during pediatric cardiac arrest to improve perfusion.

Incorrect. Oxygen is administered to stabilize respiratory failure and improve oxygen delivery.

Incorrect. A 20 mL/kg fluid bolus is standard for pediatric hypovolemic shock to restore circulating volume.

Incorrect. A compression fraction >80% ensures that the majority of CPR time is spent delivering chest compressions for optimal outcomes.

Incorrect. A compression fraction >80% ensures most of the resuscitation time is spent delivering compressions for optimal circulation.

Incorrect. A 3:1 ratio prioritizes ventilation due to the respiratory etiology of most neonatal arrests.

Incorrect. Oxygen saturation should be maintained between 94-98% to avoid hypoxia or hyperoxia post-resuscitation.

Incorrect. Hypoxia is the most common cause of bradycardia in children; oxygenation and ventilation address this underlying issue.

Incorrect. Neonatal hypovolemic shock is managed with smaller boluses of 10 mL/kg to avoid overloading the circulatory system.

Incorrect. Epinephrine is the first-line drug to improve perfusion and increase heart rate in bradycardia unresponsive to oxygenation.

Incorrect. Rescue breaths ensure oxygenation and prevent further deterioration in children with respiratory failure.

Incorrect. The compression-to-ventilation ratio for single-rescuer infant CPR is 30:2, ensuring adequate perfusion and oxygenation.

Incorrect. Magnesium sulfate stabilizes the myocardium and is administered at 25-50 mg/kg for torsades de pointes in pediatric patients.

Incorrect. Synchronized cardioversion begins at 0.5-1 J/kg to restore a stable rhythm in unstable SVT in children.

Incorrect. Hyperglycemia is not listed as one of the reversible causes of cardiac arrest (H's and T's).

Incorrect. Maintaining oxygen saturation at 94-98% avoids both hypoxia and the harmful effects of hyperoxia.

Incorrect. Intramuscular epinephrine is the first-line treatment for anaphylaxis, improving perfusion and reducing airway swelling.

Incorrect. For a child without a pulse, CPR should be initiated with compressions and ventilations at a 30:2 or 15:2 ratio.

Incorrect. Lidocaine is used as an antiarrhythmic in cardiac arrest, with a cumulative dose limit of 3 mg/kg.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the drug of choice for torsades de pointes in children.

Incorrect. Defibrillation is the primary intervention for shockable rhythms like VF and pulseless VT in pediatric cardiac arrest.

Incorrect. Oxygen administration is the first step to stabilize a child in respiratory distress and improve oxygen delivery.

Incorrect. The maximum dose of atropine for pediatric bradycardia is 1 mg for children and 3 mg for adolescents.

Incorrect. Oxygen improves perfusion and is the first-line treatment for bradycardia caused by hypoxia.

Incorrect. Magnesium sulfate is the treatment of choice for torsades de pointes and is not contraindicated.

Incorrect. Epinephrine at 0.01 mg/kg is used to enhance cardiac contractility and perfusion during neonatal resuscitation.

Incorrect. IO access is the preferred alternative to IV access in pediatric emergencies due to its rapid and reliable establishment.

Incorrect. ROSC (Return of Spontaneous Circulation) indicates the restoration of effective blood flow with a detectable pulse.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore a perfusing rhythm in pediatric cardiac arrest.

Incorrect. PEA is a non-shockable rhythm and is managed with high-quality CPR and addressing reversible causes such as hypoxia or hypovolemia.

Incorrect. If VF persists after the initial defibrillation at 2 J/kg, the next dose is 4 J/kg, and subsequent shocks should not exceed 10 J/kg.

Incorrect. A fluid bolus, typically 20 mL/kg of isotonic crystalloid, is the first step in treating hypovolemic shock in children.

Incorrect. IO access provides rapid and reliable vascular access for drug delivery during pediatric cardiac arrest.

Incorrect. Hypothermia is one of the "H's" and should be corrected to restore normal cardiac function during resuscitation.

Incorrect. The total cumulative dose of amiodarone during pediatric cardiac arrest should not exceed 15 mg/kg.

Incorrect. The initial defibrillation dose for children is 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. The two-thumb encircling technique ensures effective compressions and promotes high-quality infant CPR.

Incorrect. CPR is initiated immediately to relieve the obstruction and restore ventilation in an unresponsive child.

Incorrect. Vagal maneuvers are the first-line treatment for stable SVT to interrupt the reentrant circuit causing tachycardia.

Incorrect. Rhythm checks are performed every 2 minutes to assess the need for defibrillation or changes in treatment.

Incorrect. Epinephrine is given at a dose of 0.01 mg/kg IV every 3-5 minutes for pediatric bradycardia unresponsive to oxygenation.

Incorrect. Rescue breaths deliver oxygen to maintain adequate ventilation in children with respiratory arrest and a pulse.

Incorrect. Epinephrine at 0.01 mg/kg IV/IO is administered every 3-5 minutes to improve perfusion during pediatric cardiac arrest.

Incorrect. The total fluid bolus dose should not exceed 60 mL/kg to avoid fluid overload during resuscitation in children.

Incorrect. Amiodarone is given at 5 mg/kg IV/IO for ventricular tachycardia with a pulse to stabilize the rhythm.

Incorrect. The maximum dose of adenosine for pediatric SVT is 12 mg, administered as a rapid IV push.

Incorrect. Rhythm checks every 2 minutes minimize interruptions in compressions while assessing for shockable rhythms.

Incorrect. Intraosseous access provides rapid and reliable vascular access for drug delivery during pediatric resuscitation.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore a perfusing rhythm.

Incorrect. Amiodarone is given at a dose of 5 mg/kg IV/IO during VF or pulseless VT to stabilize the rhythm.

Incorrect. Synchronized cardioversion begins at 0.5-1 J/kg for pediatric SVT and may increase to 2 J/kg if needed.

Incorrect. Synchronized cardioversion begins at 0.5-1 J/kg for pediatric SVT and increases as needed based on clinical response.

Incorrect. Oxygen saturation should be maintained between 94-98% to prevent hypoxia or hyperoxia during resuscitation.